Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Erlotinib plus Radiotherapy in Unresectable NSCLC
NCT00466089Phase 2Unknown
- Sponsor
- Hospital Universitario de Navarra
- Start
- Mar 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of erlotinib in non-small cell lung cancer (NSCLC), sponsored by Hospital Universitario de Navarra. Status: unknown.
02
Drugs
erlotinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT00466089.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00466089.